国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

至今,GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫(yī)藥類雜志引用近萬次,處于行業(yè)領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發(fā)表科研成果,再次證明GenScript 有能力幫助業(yè)內科學家Make research easy.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

Vaccines (Basel). 2023-02; 
Aleksandr V Kudriavtsev, Anna V Vakhrusheva, Nickolay A Kryuchkov, Maria E Frolova, Konstantin A Blagodatskikh, Taras V Ivanishin, Milana Djonovic, Ekaterina A Romanovskaya-Romanko, Anton N Kovalenko, Dmitry A Lioznov, Tatiana G Zubkova, Svetlana V Teplykh, Rodion A Oseshnyuk, Marina A Stukova, Artur A Isaev, Igor V Krasilnikov
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis … ) (GenScript, Piscataway, New Jersey, US) that was used in this study. There is a good correlation between PRNT values and the binding inhibition values obtained with GenScript’s … Get A Quote

摘要

關鍵詞

Betuvax-CoV-2, COVID-19, SARS-CoV-2, betulin, clinical trial, subunit vaccine
              主站蜘蛛池模板: 鄱阳县| 衡南县| 乌恰县| 阿巴嘎旗| 和硕县| 泽普县| 道孚县| 北碚区| 台江县| 庆阳市| 大关县| 定安县| 凤凰县| 孝义市| 兴义市| 五台县| 哈巴河县| 社旗县| 民丰县| 珲春市| 玉田县| 呼伦贝尔市| 浦江县| 江油市| 普兰县| 琼结县| 营山县| 天津市| 雅江县| 抚远县| 神池县| 来凤县| 河津市| 嘉黎县| 泉州市| 平邑县| 通城县| 民权县| 五原县| 石台县| 滨州市|